DETERMINATION OF PHYSICAL ACTIVITY LEVELS OF PATIENTS WITH DIABETES MELLITUS AND EVALUATION OF ITS RELATIONSHIP WITH TREATMENT COMPLIANCE

Objectives: Physical activity is a crucial component of the treatment of Diabetes Mellitus (DM). This study aimed to determine the physical activity levels of patients with DM and evaluate the relationship between their adherence to treatment. Materials and Methods: The study was designed as a single-center, prospective, analytical study. It was conducted with patients who applied to the Family Medicine Outpatient Clinic for any reason, those who had a diagnosis of DM for at least one year. Sociodemographic data, anthropometric measurements, fasting blood glucose, and HbA1C levels were recorded. Physical activity levels were assessed using the General Practice Physical Activity Questionnaire (GPPAQ) and the International Physical Activity Questionnaire (IPAQ). The levels of compliance with drug treatment were assessed using the Modified Morisky Medication Adherence Scale-8 (MMMAS-8). Results: The mean age of 237 people included in the study was 51.32 ± 8.62 years (25-65), and most were women (n=141; 59.49%). The majority of the participants were physically inactive. (according to IPAQ n=143, 60.34%; GPPAQ n=161, 67.93%). 55.70% (n=132) had a moderate-high level of treatment compliance. No statistically significant correlation was determined between both scales measuring physical activity level and compliance of individuals to drug treatment (p=0.110 for GPPAQ; p=0.714 for IPAQ). Conclusion: No significant correlation was found between the physical activity levels of patients with DM and their compliance with drug therapy. However, it has been observed that the results obtained with GPPAQ, a new measurement tool that can be easily applied in primary care, are also instructive.

PDF

___

1. TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi Ve İzlem Kılavuzu-2020 [Internet]. https://temd.org.tr/admin/uploads/tbl_kilavuz/20200625154506-2020tbl_kilavuz86bf012d90.pdf (Accessed: 20.10.2021)
2. Global recommendations on physical activity for health. Geneva: WHO, 2010 [Internet]. https://www.who.int/publications/i/item/9789241599979 (Accessed:20.10.2021) 3. Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017;84(7):15-21.
4. TSBHS. Türkiye Diyabet Programı 2015-2020, Ankara. Sağlık Bakanlığı Yayınları. 2014(816):13.
5. Oliveira C, Simões M, Carvalho J, Ribeiro J. Combined exercise for people with type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2012;98(2):187-98.
6. Duarte CK, Almeida JC, Merker AJ, Brauer Fde, Rodrigues TC. Physical activity level and exercise in patients with diabetes mellitus. Rev Assoc Med Bras(English Edition). 2012;58(2): 215-21.
7. Çolak TK, Acar G, Dereli E, et al. Association between the physical activity level and the quality of life of patients with type 2 diabetes mellitus. J Phys Ther Sci. 2016;28:142–47.
8. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence:Its importance in cardiovascular outcomes. Circulation. 2009;119:3028-35 .
9. Krapek K, King K, Warren SS et al. Medication adherence and associated hemoglobin A1C in type 2 diabetes. Ann Pharmacother. 2004; 38(9):1357–62
10. Rubin Richard R. Adherence to pharmacologic therapy in patients with Type 2 diabetes mellitus. Am J Med. 2005; 118 Suppl 5A:27–34.
11. Asche C, Lafleur J, Conner C. Review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics. 2011; 33:74-109.
12. Wood B. Medication adherence, the real problem when treating chronic conditions. US Pharm. 2012;37(4):3-6.
13. Tominaga Y, Aomori T, Hayakawa T, Morisky DE, Takahashi K, Mochizuki M. Relationship between medication adherence and glycemic control in Japanese patients with type 2 diabetes. Pharmazie. 2018;73(10):609-12.
14. Hammad MA, Mohamed Noor DA, Syed Sulaiman SA. The effect of patient's adherence on HBa1c control. Archives of Medical and Pharmaceutical Sciences Research (AMPSR):2017;01(01):30-5.
15. Strath SJ, Kaminsky LA, Ainsworth BE, et al. Guide to the assessment of physical activity: Clinical and research applications: a scientific statement from the American Heart Association. Circulation. 2013;128(20):2259-79.
16. Department of Health. The general practice physical activity questionnaire (GPPAQ): a screening tool to assess adult physical activity levels within primary care. London: Department of Health, 2009.
17. Kaya Noğay A, Özen M. Birinci basamak için fiziksel aktivite anketinin Türkçe uyarlamasının geçerlilik ve güvenilirliği. Konuralp Medical Journal. 2019;11(1);1-8.
18. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-95.
19. Saglam M, Arikan H, Savci S, et al. International physical activity questionnaire: reliability and validity of the Turkish version. Perceptual and motor skills. 2010; 111(1): 278-84.
20. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J ClinHypertens. 2008;10:348-54.
21. Sayiner ZA, Savaş E, Kul S, Morisky DE. Validity and reliability of the Turkish version of the 8-Item Morisky Medication Adherence Scale in patients with type 2 diabetes. Eur J Ther 2020; 26(1): 47-52.
22. Ranasinghe DC, Ranasinghe P, Jayawardena R, Matthews DR, Katulanda P. Evaluation of physical activity among adults with diabetes mellitus from Sri Lanka. Int Arch Med. 2014;7:15.
23. Mynarski W, Psurek A, Borek Z, Rozpara M, Grabara M, Strojek K. Declared and real physical activity in patients with type 2 diabetes mellitus as assessed by the International Physical Activity Questionnaire and Caltrac accelerometer monitor: a potential tool for physical activity assessment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;98(1):46-50.
24. Wisse W, Boer Rookhuizen M, de Kruif MD, et al. Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients. Diabetes Res Clin Pract. 2010;88(2):e10-e13.
25. Daniele TM, Bruin VM, Oliveira DS, Pompeu CM, Forti AC. Associations among physical activity, comorbidities, depressive symptoms and health-related quality of life in type 2 diabetes. Arq Bras Endocrinol Metabol. 2013;57(1):44-50.
26. Boniol M, Dragomir M, Autier P, Boyle P. Physical activity and change in fasting glucose and HbA1c: a quantitative meta-analysis of randomized trials. Acta Diabetol. 2017;54(11):983-991.
27. Cradock KA, ÓLaighin G, Finucane FM, Gainforth HL, Quinlan LR, Ginis KA. Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: A systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2017;14(1):18.
28. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790-99.
29. Özkaptan BB, Kapucu S, Demirci İ. Relationship between adherence to treatment and acceptance of illness in patients with type 2 diabetes. CukurovaMedicalJournal. 2019; 44(1), 447-54.
30. Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary health care facility in Ogbomosho, Nigeria. Malawi Medical Journal. 2015;27(2): 65-70.